HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ferdinandusse, S. Articles by Wanders, R. J. A. Search for Related Content PubMed PubMed Citation Articles by Ferdinandusse, S. Articles by Wanders, R. J. A. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 41, 336-342, March 2000
Copyright © 2000 by Lipid Research, Inc.

Original Article

Peroxisomal fatty acid oxidation disorders and 58 kDa sterol carrier protein X (SCPx): activity measurements in liver and fibroblasts using a newly developed method

Correspondence to: Ronald J. A. Wanders

Sterol carrier protein X (SCPx) plays a crucial role in the peroxisomal oxidation of branched-chain fatty acids. To investigate whether patients with an unresolved defect in peroxisomal ß-oxidation are deficient for SCPx, we developed a novel and specific assay to measure the activity of SCPx in both liver and fibroblast homogenates. The substrate used in the assay, 3,7,12-trihydroxy-24-keto-5ß-cholestanoyl-CoA (24-keto-THC-CoA), is produced by preincubating the enoyl-CoA of the bile acid intermediate THCA with a lysate from the yeast Saccharomyces cerevisiae expressing human D-bifunctional protein. After the preincubation period, liver or fibroblast homogenate is added plus CoASH, and the production of choloyl-CoA is determined by HPLC. The specificity of the assay was demonstrated by the finding of a full deficiency in fibroblasts from an SCPx knock-out mouse. In addition to SCPx activity measurements in fibroblasts from patients with a defect in peroxisomal ß-oxidation of unresolved etiology, we studied the stability and activity of SCPx in fibroblasts from patients with Zellweger syndrome, which lack functional peroxisomes.

We found that SCPx is not only stable in the cytosol, but displays a higher activity in fibroblasts from patients with Zellweger syndrome than in control fibroblasts. Furthermore, in all patients studied with a defect in peroxisomal ß-oxidation of unknown origin, SCPx was found to be normally active, indicating that human SCPx deficiency remains to be identified.—Ferdinandusse, S., S. Denis, E. van Berkel, G. Dacremont, and R. J. A. Wanders. Peroxisomal fatty acid oxidation disorders and 58 kDA sterol carrier protein X (SCPx): activity measurements in liver and fibroblasts using a newly developed method. J. Lipid Res. 2000. 41: 336;–342

Supplementary key words: SCPx knock-out mouse, peroxisomal ß-oxidation disorders, Zellweger syndrome

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Gloerich, N. van Vlies, G. A. Jansen, S. Denis, J. P. N. Ruiter, M. A. van Werkhoven, M. Duran, F. M. Vaz, R. J. A. Wanders, and S. Ferdinandusse A phytol-enriched diet induces changes in fatty acid metabolism in mice both via PPAR{alpha}-dependent and -independent pathways J. Lipid Res., April 1, 2005; 46(4): 716 - 726. [Abstract] [Full Text] [PDF]

				J. Gootjes, F. Skovby, E. Christensen, R. J.A. Wanders, and S. Ferdinandusse Reinvestigation of trihydroxycholestanoic acidemia reveals a peroxisome biogenesis disorder Neurology, June 8, 2004; 62(11): 2077 - 2081. [Abstract] [Full Text] [PDF]

				B. P. Atshaves, H. R. Payne, A. L. McIntosh, S. E. Tichy, D. Russell, A. B. Kier, and F. Schroeder Sexually dimorphic metabolism of branched-chain lipids in C57BL/6J mice J. Lipid Res., May 1, 2004; 45(5): 812 - 830. [Abstract] [Full Text] [PDF]

				T. B. Dansen, G. J. P. L. Kops, S. Denis, N. Jelluma, R. J. A. Wanders, J. L. Bos, B. M. T. Burgering, and K. W. A. Wirtz Regulation of sterol carrier protein gene expression by the Forkhead transcription factor FOXO3a J. Lipid Res., January 1, 2004; 45(1): 81 - 88. [Abstract] [Full Text] [PDF]

				Y. Jia, C. Qi, Z. Zhang, T. Hashimoto, M. S. Rao, S. Huyghe, Y. Suzuki, P. P. Van Veldhoven, M. Baes, and J. K. Reddy Overexpression of Peroxisome Proliferator-activated Receptor-{alpha} (PPAR{alpha})-regulated Genes in Liver in the Absence of Peroxisome Proliferation in Mice Deficient in both L- and D-Forms of Enoyl-CoA Hydratase/Dehydrogenase Enzymes of Peroxisomal {beta}-Oxidation System J. Biol. Chem., November 21, 2003; 278(47): 47232 - 47239. [Abstract] [Full Text] [PDF]

				B. P. Atshaves, S. M. Storey, and F. Schroeder Sterol carrier protein-2/sterol carrier protein-x expression differentially alters fatty acid metabolism in L cell fibroblasts J. Lipid Res., September 1, 2003; 44(9): 1751 - 1762. [Abstract] [Full Text] [PDF]

				F. Schroeder, A. Frolov, O. Starodub, B. B. Atshaves, W. Russell, A. Petrescu, H. Huang, A. M. Gallegos, A. McIntosh, D. Tahotna, et al. Pro-sterol Carrier Protein-2. ROLE OF THE N-TERMINAL PRESEQUENCE IN STRUCTURE, FUNCTION, AND PEROXISOMAL TARGETING J. Biol. Chem., August 11, 2000; 275(33): 25547 - 25555. [Abstract] [Full Text] [PDF]

				H. Otera, M. Nishimura, K. Setoguchi, T. Mori, and Y. Fujiki Biogenesis of Nonspecific Lipid Transfer Protein and Sterol Carrier Protein x. STUDIES USING PEROXISOME ASSEMBLY-DEFECTIVE pex CELL MUTANTS J. Biol. Chem., January 19, 2001; 276(4): 2858 - 2864. [Abstract] [Full Text] [PDF]